Cell & Gene Therapy Drug Delivery Devices Market Growth Trends, Volume Insights & Outlook 2030

The Cell & Gene Therapy Drug Delivery Devices Market report by MarkNtel Advisors provides an in-depth analysis of market size, share, and growth prospects, offering valuable insights for stakeholders.

Cell & Gene Therapy Drug Delivery Devices Market Size & Insights

The Global Cell & Gene Therapy Drug Delivery Devices Market size was valued at around USD 1.27 billion in 2024 and is projected to reach USD 2.32 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.53% during the forecast period, i.e., 2025-30.

The market is driven primarily by massive funding by numerous leading players in the technological advancements to bring cost-effective therapies & devices, coupled with the increasing number of FDA approvals for cell & gene therapies & clinical trials. Furthermore, the rising number of FDA Approvals of Cell & Gene Therapies and clinical trials to develop new medical products and provide patients with increased therapeutic choices shall also boost the market in the coming years

What are the Key Driver in the Cell & Gene Therapy Drug Delivery Devices Market??

Growing Occurrence of Chronic and Genetic Disorders – One of the leading drivers propelling the global cell and gene therapy drug delivery devices market is the increasing prevalence of chronic diseases, particularly cancer, diabetes, and genetic disorders. As these complex conditions become more widespread, there is a growing demand for advanced therapies that can offer targeted and effective treatment options. Cell and gene therapies have emerged as transformative solutions, and their success relies heavily on innovative drug delivery devices that ensure precise administration, optimal dosage, and improved patient outcomes. This surge in chronic disease cases not only fuels the adoption of these therapies but also accelerates the development and deployment of specialized delivery devices, thereby driving robust market growth.

What are the Key Segments in the Cell & Gene Therapy Drug Delivery Devices Market?

The Cell & Gene Therapy Drug Delivery Devices is categorized into notable segments, which help in understanding the structure, dynamics, and opportunities within the market. These segments are typically based on:

By Product Type

Sub-retinal Injection Cannula
Extension Tube
Intravenous Catheter
Sterile Insulin Syringe
- Size 1.0 ML, 31-Gauge Needle
- Size 0.5 ML, 22-Gauge Needle
Pre-Filled Syringe
- Size 1.0 ML, 22-26 Gauge Needle
- Size 4.0 ML, 22-26 Gauge Needle
Infusion Bags
- Infusion Bags (Size 10 ML to 50 ML)
- Infusion Bags (Size 68 ML)
- Infusion Bags (Size 60 ML)
- Infusion Bags (Size Up to 65 ML)

By Technology

Microchip Technology
Nano-Technology
Lipid Nanoparticles

By Commercialized Drugs

Luxturna
Kymriah
Yescarta
Zolgensma
Provenge
Strimvelis

Of them all, Luxturna & Yescarta overpowered the Global Cell & Gene Therapy Drug Delivery Devices Market in 2024.

By End-User

Pharmaceuticals & Biotechnology Company
Academic & Research Institute
Hospitals & Clinics.

Boost Your Company's Decisions by Getting a Free Sample Right Away- https://www.marknteladvisors.com/query/request-sample/cell-gene-therapy-drug-delivery-devices-market.html

How does geographical analysis highlight in the Cell & Gene Therapy Drug Delivery Devices market?

By Region

o North America

o South America

o Europe

o Asia-Pacific

o The Middle East and Africa

Of all the regions, North America attained majority of revenue share and is anticipated to prevail the same trend in the forecast period.

Who are the Key Players in Cell & Gene Therapy Drug Delivery Devices Market?

Amgen Inc.
Bausch & Lomb Incorporated
Becton, Dickinson and Company
Bluebird bio Inc.
Castle Creek Biosciences, Inc. (Fibrocell Science, Inc.)
Dendreon Pharmaceuticals LLC
Helixmith Co. Ltd (ViroMed Co., Ltd)
Human Stem Cells Institute
Kite Pharma Inc.
Kolon TissueGene, Inc.
Novartis AG
Orchard Therapeutics plc.
Pfizer Inc.
Renova Therapeutics
Spark Therapeutics Inc.
uniQure N.V.
Vericel Corporation.

Browse Full Reports – https://www.marknteladvisors.com/research-library/cell-gene-therapy-drug-delivery-devices-market.html

Cell & Gene Therapy Drug Delivery Devices Market News

2024: Pfizer collaborated with UT Southwestern Medical Center to develop improved RNA delivery technologies for genetic medicine therapies. This partnership aims to advance the understanding of genetic medicines, expand the use of artificial intelligence (AI) design methodologies, and lead to the development of new delivery technologies for potential therapies.

Key pillars of the research methodology include:

Scope & Research Design – Clearly defined objectives with tailored qualitative and quantitative methods, backed by precise timelines and budgets.
Sample Selection & Data Collection – Representative samples achieved through proven techniques like random and stratified sampling, supported by reliable tools such as surveys, interviews, and observations.
Data Analysis & Validation – Rigorous cleaning, advanced statistical modeling, and thematic analysis ensure accuracy, reliability, and minimal bias.
Forecasting & Finalization – Predictive modeling and time-series analysis anticipate future market behaviors, presented through insightful reports with charts, graphs, and strategic recommendations.

"Our methodology reflects the trust businesses place in us. By combining innovation with precision, we deliver not just numbers, but clarity and direction for decision-makers worldwide," said a spokesperson for MarkNtel Advisors.

Why This MarkNtel Advisors Research Report:

In-depth Market Analysis: Understand trends and dynamics shaping growth.
Segmented Insights: Target specific segments for focused strategies.
Geographical Performance: Assess market opportunities by geographic area.
Emerging Technologies: Discover advancements like AI integration.
Risk Identification: Pinpoint challenges to inform strategic planning.
Future Forecasts: Prepare for market changes with actionable projections.

Gain exclusive access to our comprehensive insights on the Future of Cell & Gene Therapy Drug Delivery Devices Market. With tailored licensing options, including Mini Report Pack, Excel Data Pack, Single User, Multiuser, and Enterprise Packs, our research empowers organizations to navigate dynamic market trends effectively.

Select a License That Matches Your Business Requirements with Instant Offer – https://www.marknteladvisors.com/pricing/cell-gene-therapy-drug-delivery-devices-market.html

Our Trusted Experts Are Here to Help:

At MarkNtel Advisors, we are committed to delivering data-driven insights and strategic intelligence that empower your business decisions. Whether you have a question, need customized research, or want to explore partnership opportunities, our team is here to support you every step of the way.